Published in Surg Neurol Int on November 16, 2015
Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis. Chin Med J (Engl) (2016) 0.78
TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain (2017) 0.78
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? Neural Regen Res (2016) 0.78
Immune response in peripheral axons delays disease progression in SOD1(G93A) mice. J Neuroinflammation (2016) 0.75
ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. Front Cell Neurosci (2017) 0.75
Frontotemporal Dementia in Amyotrophic Lateral Sclerosis: From Rarity to Reality? Neurol Int (2016) 0.75
Amyotrophic lateral sclerosis mimic syndromes. Iran J Neurol (2016) 0.75
Major Histocompatibility Complex I Expression by Motor Neurons and Its Implication in Amyotrophic Lateral Sclerosis. Front Neurol (2016) 0.75
Interaction of Mitochondria with the Endoplasmic Reticulum and Plasma Membrane in Calcium Homeostasis, Lipid Trafficking and Mitochondrial Structure. Int J Mol Sci (2017) 0.75
Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases. Transl Neurodegener (2017) 0.75
Novel miR-b2122 regulates several ALS-related RNA-binding proteins. Mol Brain (2017) 0.75
Inflammatory and non-inflammatory monocytes as novel prognostic biomarkers of survival in SOD1G93A mouse model of Amyotrophic Lateral Sclerosis. PLoS One (2017) 0.75
Induced Pluripotent Stem Cell Neuronal Models for the Study of Autophagy Pathways in Human Neurodegenerative Disease. Cells (2017) 0.75
Correlations between slow-rate repetitive nerve stimulation and characteristics associated with amyotrophic lateral sclerosis in Chinese patients. J Phys Ther Sci (2017) 0.75
Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol (2001) 24.36
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 15.38
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med (1994) 8.82
ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron (2006) 7.82
Amyotrophic lateral sclerosis. N Engl J Med (2001) 7.37
Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci (2006) 6.53
Amyotrophic lateral sclerosis. Lancet (2011) 5.86
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol (2009) 5.65
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol (2007) 5.46
Poisoning due to organophosphate insecticides. Acute and chronic manifestations. Am J Med (1971) 5.20
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India (2004) 5.10
A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: a gene identification study. Lancet Neurol (2011) 5.01
Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet (2009) 4.38
Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol (2000) 4.17
Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet (1996) 4.11
Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol (2007) 3.96
The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology (2002) 3.91
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis. Nat Genet (2006) 3.88
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet (2004) 3.72
The induction of pain: an integrative review. Prog Neurobiol (1999) 3.70
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry (2010) 3.66
Incidence of amyotrophic lateral sclerosis in Europe. J Neurol Neurosurg Psychiatry (2009) 3.35
RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron (2013) 3.25
Prevalence of depression by race/ethnicity: findings from the National Health and Nutrition Examination Survey III. Am J Public Health (2005) 3.23
Phase II/III randomized trial of TCH346 in patients with ALS. Neurology (2007) 3.22
Corticobasal degeneration. Brain (1989) 3.20
Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model. Science (2000) 3.12
Criteria for the diagnosis of corticobasal degeneration. Neurology (2013) 3.07
Toxicity of familial ALS-linked SOD1 mutants from selective recruitment to spinal mitochondria. Neuron (2004) 2.94
Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain (2005) 2.94
Amyotrophic lateral sclerosis. Lancet (2007) 2.91
Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol (1996) 2.82
Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci (1999) 2.81
Amyotrophic lateral sclerosis. Orphanet J Rare Dis (2009) 2.76
Hereditary spastic paraplegia. Curr Neurol Neurosci Rep (2006) 2.75
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.73
Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci (2012) 2.68
Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria. Neuron (2004) 2.53
Fatigue and depression are associated with poor quality of life in ALS. Neurology (2003) 2.49
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev (2012) 2.49
Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000. J Neurol Neurosurg Psychiatry (2003) 2.49
Omega 3 fatty acids and cardiovascular disease--fishing for a natural treatment. BMJ (2004) 2.47
Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron (1998) 2.45
Selective association of misfolded ALS-linked mutant SOD1 with the cytoplasmic face of mitochondria. Proc Natl Acad Sci U S A (2008) 2.35
Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet (2007) 2.32
The natural history of primary lateral sclerosis. Neurology (2006) 2.31
EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol (2011) 2.27
Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion (2005) 2.24
Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues. J Neurol Neurosurg Psychiatry (2008) 2.24
Subcutaneous IGF-1 is not beneficial in 2-year ALS trial. Neurology (2008) 2.17
A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes. Arch Neurol (2009) 2.17
A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord (2000) 2.12
Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem (1987) 2.09
Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat Rev Neurol (2011) 2.08
Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J Neurol Neurosurg Psychiatry (2011) 2.08
Multiple system atrophy. Lancet Neurol (2004) 2.04
Survival in amyotrophic lateral sclerosis. The role of psychological factors. Arch Neurol (1994) 2.02
A mutation in dynein rescues axonal transport defects and extends the life span of ALS mice. J Cell Biol (2005) 2.01
Genetics of familial amyotrophic lateral sclerosis. Neurology (2008) 2.00
GDNF secreting human neural progenitor cells protect dying motor neurons, but not their projection to muscle, in a rat model of familial ALS. PLoS One (2007) 1.99
Neuroprotective agents for clinical trials in ALS: a systematic assessment. Neurology (2006) 1.99
Prevalence and incidence of Parkinson's disease in Europe. Eur Neuropsychopharmacol (2005) 1.88
Hereditary spastic paraparesis: a review of new developments. J Neurol Neurosurg Psychiatry (2000) 1.87
Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004. J Neurol Neurosurg Psychiatry (2007) 1.86
Oxidative stress in ALS: key role in motor neuron injury and therapeutic target. Free Radic Biol Med (2009) 1.82
Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev (2004) 1.81
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy. Neurology (2010) 1.80
Prevalence of depressive disorders and change over time in late-stage ALS. Neurology (2005) 1.80
Mutant superoxide dismutase 1 forms aggregates in the brain mitochondrial matrix of amyotrophic lateral sclerosis mice. J Neurosci (2005) 1.79
Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med (1999) 1.79
Mutations of FUS gene in sporadic amyotrophic lateral sclerosis. J Med Genet (2009) 1.79
Motor neuron disease. J Neurol Neurosurg Psychiatry (1994) 1.78
Occupational exposures and amyotrophic lateral sclerosis. A population-based case-control study. Am J Epidemiol (1997) 1.73
Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2010) 1.71
A study of riluzole in the treatment of advanced stage or elderly patients with amyotrophic lateral sclerosis. J Neurol (2002) 1.69
Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci U S A (2010) 1.66
Respiratory aspects of neurological disease. J Neurol Neurosurg Psychiatry (1999) 1.61
The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci (2001) 1.60
The prognosis of adult-onset motor neuron disease: a prospective study based on the Scottish Motor Neuron Disease Register. J Neurol (1993) 1.60
Nordihydroguaiaretic acid increases glutamate uptake in vitro and in vivo: therapeutic implications for amyotrophic lateral sclerosis. Exp Neurol (2008) 1.59
Lead exposure and amyotrophic lateral sclerosis. Epidemiology (2002) 1.59
Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. J Pharmacol Exp Ther (2007) 1.55
Age and founder effect of SOD1 A4V mutation causing ALS. Neurology (2009) 1.55
A hypothesis of chronic back pain: ligament subfailure injuries lead to muscle control dysfunction. Eur Spine J (2005) 1.55
Amyotrophic lateral sclerosis in South-East England: a population-based study. The South-East England register for amyotrophic lateral sclerosis (SEALS Registry). Neuroepidemiology (2007) 1.52
Sensitivity and specificity of threshold tracking transcranial magnetic stimulation for diagnosis of amyotrophic lateral sclerosis: a prospective study. Lancet Neurol (2015) 1.52
Primary lateral sclerosis. Muscle Nerve (2007) 1.52
Head injury and amyotrophic lateral sclerosis. Am J Epidemiol (2007) 1.50
Large proportion of amyotrophic lateral sclerosis cases in Sardinia due to a single founder mutation of the TARDBP gene. Arch Neurol (2011) 1.48
Diagnosis and treatment of bulbar symptoms in amyotrophic lateral sclerosis. Nat Clin Pract Neurol (2008) 1.48
Consistency of the Babinski reflex and its variants. Eur J Neurol (2008) 1.47
Disease progression in amyotrophic lateral sclerosis: predictors of survival. Muscle Nerve (2002) 1.47
Pentoxifylline in ALS: a double-blind, randomized, multicenter, placebo-controlled trial. Neurology (2006) 1.47
Mitochondrial respiratory chain function in skeletal muscle of ALS patients. Ann Neurol (2002) 1.47
Mitochondrial enzyme activity in amyotrophic lateral sclerosis: implications for the role of mitochondria in neuronal cell death. Ann Neurol (1999) 1.46
FUS and TARDBP but not SOD1 interact in genetic models of amyotrophic lateral sclerosis. PLoS Genet (2011) 1.46